Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editing

Author:

Diaz Quiroz Juan Felipe1,Ojha Namrata1,Shayhidin Elnur E2,De Silva Dasuni2,Dabney Jesse2,Lancaster Amy2,Coull James2,Milstein Stuart2,Fraley Andrew W2,Brown Christopher R2,Rosenthal Joshua J C1ORCID

Affiliation:

1. Eugene Bell Center for Regenerative Biology and Tissue Engineering, The Marine Biological Laboratory , Woods Hole, MA, USA

2. Korro Bio Inc. , Cambridge , MA, USA

Abstract

Abstract A major challenge confronting the clinical application of site-directed RNA editing (SDRE) is the design of small guide RNAs (gRNAs) that can drive efficient editing. Although many gRNA designs have effectively recruited endogenous Adenosine Deaminases that Act on RNA (ADARs), most of them exceed the size of currently FDA-approved antisense oligos. We developed an unbiased in vitro selection assay to identify short gRNAs that promote superior RNA editing of a premature termination codon. The selection assay relies on hairpin substrates in which the target sequence is linked to partially randomized gRNAs in the same molecule, so that gRNA sequences that promote editing can be identified by sequencing. These RNA substrates were incubated in vitro with ADAR2 and the edited products were selected using amplification refractory mutation system PCR and used to regenerate the substrates for a new round of selection. After nine repetitions, hairpins which drove superior editing were identified. When gRNAs of these hairpins were delivered in trans, eight of the top ten short gRNAs drove superior editing both in vitro and in cellula. These results show that efficient small gRNAs can be selected using our approach, an important advancement for the clinical application of SDRE.

Funder

Korro Bio Inc.

Marine Biological Laboratory

Publisher

Oxford University Press (OUP)

Subject

Genetics

Reference47 articles.

1. Splice-switching antisense oligonucleotides as therapeutic drugs;Havens;Nucleic Acids Res.,2016

2. The delivery of therapeutic oligonucleotides;Juliano;Nucleic Acids Res.,2016

3. RNA-targeted therapeutics;Crooke;Cell Metab.,2018

4. MRNA-based therapeutics-developing a new class of drugs;Sahin;Nat. Rev. Drug Discov.,2014

5. mRNA-based protein replacement therapy for the heart;Magadum;Mol. Ther.,2019

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3